Last reviewed · How we verify

Tadalafil versus tamsulosin as MET

Beni-Suef University · FDA-approved active Small molecule

Tadalafil versus tamsulosin as MET is a PDE5 inhibitor (tadalafil) vs. alpha-1A adrenergic antagonist (tamsulosin) Small molecule drug developed by Beni-Suef University. It is currently FDA-approved for Benign prostatic hyperplasia with lower urinary tract symptoms, Erectile dysfunction (tadalafil).

Tadalafil is a phosphodiesterase-5 inhibitor that relaxes smooth muscle in the prostate and bladder, improving urinary flow; tamsulosin is an alpha-1A adrenergic antagonist that selectively blocks receptors in the prostate to reduce urinary obstruction.

Tadalafil is a phosphodiesterase-5 inhibitor that relaxes smooth muscle in the prostate and bladder, improving urinary flow; tamsulosin is an alpha-1A adrenergic antagonist that selectively blocks receptors in the prostate to reduce urinary obstruction. Used for Benign prostatic hyperplasia with lower urinary tract symptoms, Erectile dysfunction (tadalafil).

At a glance

Generic nameTadalafil versus tamsulosin as MET
SponsorBeni-Suef University
Drug classPDE5 inhibitor (tadalafil) vs. alpha-1A adrenergic antagonist (tamsulosin)
TargetPDE5 (tadalafil) vs. alpha-1A adrenergic receptor (tamsulosin)
ModalitySmall molecule
Therapeutic areaUrology / Benign Prostatic Hyperplasia
PhaseFDA-approved

Mechanism of action

This appears to be a comparative study (versus) rather than a single drug entity. Tadalafil works by inhibiting PDE5, increasing cGMP levels and promoting smooth muscle relaxation in lower urinary tract tissues. Tamsulosin selectively antagonizes alpha-1A receptors on prostatic smooth muscle, reducing dynamic obstruction. Both are used for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) but through distinct mechanisms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tadalafil versus tamsulosin as MET

What is Tadalafil versus tamsulosin as MET?

Tadalafil versus tamsulosin as MET is a PDE5 inhibitor (tadalafil) vs. alpha-1A adrenergic antagonist (tamsulosin) drug developed by Beni-Suef University, indicated for Benign prostatic hyperplasia with lower urinary tract symptoms, Erectile dysfunction (tadalafil).

How does Tadalafil versus tamsulosin as MET work?

Tadalafil is a phosphodiesterase-5 inhibitor that relaxes smooth muscle in the prostate and bladder, improving urinary flow; tamsulosin is an alpha-1A adrenergic antagonist that selectively blocks receptors in the prostate to reduce urinary obstruction.

What is Tadalafil versus tamsulosin as MET used for?

Tadalafil versus tamsulosin as MET is indicated for Benign prostatic hyperplasia with lower urinary tract symptoms, Erectile dysfunction (tadalafil).

Who makes Tadalafil versus tamsulosin as MET?

Tadalafil versus tamsulosin as MET is developed and marketed by Beni-Suef University (see full Beni-Suef University pipeline at /company/beni-suef-university).

What drug class is Tadalafil versus tamsulosin as MET in?

Tadalafil versus tamsulosin as MET belongs to the PDE5 inhibitor (tadalafil) vs. alpha-1A adrenergic antagonist (tamsulosin) class. See all PDE5 inhibitor (tadalafil) vs. alpha-1A adrenergic antagonist (tamsulosin) drugs at /class/pde5-inhibitor-tadalafil-vs-alpha-1a-adrenergic-antagonist-tamsulosin.

What development phase is Tadalafil versus tamsulosin as MET in?

Tadalafil versus tamsulosin as MET is FDA-approved (marketed).

What are the side effects of Tadalafil versus tamsulosin as MET?

Common side effects of Tadalafil versus tamsulosin as MET include Headache, Dyspepsia, Back pain, Dizziness, Orthostatic hypotension, Retrograde ejaculation.

What does Tadalafil versus tamsulosin as MET target?

Tadalafil versus tamsulosin as MET targets PDE5 (tadalafil) vs. alpha-1A adrenergic receptor (tamsulosin) and is a PDE5 inhibitor (tadalafil) vs. alpha-1A adrenergic antagonist (tamsulosin).

Related